Jeisys Medical Inc. announced a private placement of 553,311 registered redeemable convertible preferred stocks at a price of KRW 7,230 for gross proceeds of KRW 4,000,438,530 on May 24, 2019. The company is raising funding through third party allotment. The transaction will include participation from BNH Investment LLC for 276,655 shares, DAYLI Partners for 138,328 shares and LSK Investment for 138,328 shares. The convertible preferred stock will be converted into 553,311 common shares. The transaction is expected to close on June 10, 2019. The dividend payout date of new shares is December 31, 2018. The scheduled delivery date of new share certificates is June 24, 2019. The transaction has been approved by the board of directors.